Cancer Trends Progress Report - Prostate Cancer Treatment
Links shared publicly online about this topic.
- 1,211total visits
Cancer Trends Progress Report - Prostate Cancer Treatment
View full resource at progressreport.cancer.gov
Tags: Cancer, Prostate Cancer, Prostate, Men's Health
Most Recently Shared on April 26, 2010 at 10:26 pm By:
Cancer Trends Progress Report - Prostate Cancer Treatment http://bit.ly/dzsAac
More Targeted Treatments Key to Progress in War on Cancer: Report
consumer.healthday.com — “More Targeted Treatments Key to Progress in War on Cancer: Report” View full resource at consumer.healthday.com
Most Recently Shared on November 4, 2011 at 3:14 pm By:
More Targeted Treatments Key to Progress in War on Cancer: Report. http://t.co/Xjos2iGC
Medical News: Since 1970s, 'Unimagined Progress' Seen in Cancer Research - in Oncology/Hematology, Other Cancers from MedPage Today
medpagetoday.com — “The nation is in a defining time to defeat cancer given the unimagined progress in cancer research and treatment options, according to a new report from the American Association for Cancer Researc” View full resource at medpagetoday.com
Most Recently Shared on September 20, 2011 at 12:23 pm By:
Since 1970s, 'Unimagined Progress' Seen in Cancer Research http://t.co/40UCsdgo
New hope with 'I Spy' cancer treatment - Bing Videos
bing.com — “Aug. 8: A new trend in medical treatment: personalized medicine to possibly cure some of the most deadly forms of cancer. NBC's Doreen Gentzler reports.” View full resource at bing.com
Most Recently Shared on August 10, 2011 at 2:29 pm By:
Dr. Minetta Liu joined our faculty of the Breast Cancer Program in July 2001. She leads the reasearch for a... http://fb.me/19D0cxeVh
Using math to fight cancer
eurekalert.org — “Researchers from the University of Miami and the University of Heidelberg in Germany have developed a mathematical model to understand and predict the progress of a tumor, from its early stages to metastasis, in hopes of creating highly personalized treatment strategies for patients who have cancer. The findings are published in Nature's new online journal Scientific Reports.” View full resource at eurekalert.org
Most Recently Shared on August 1, 2011 at 3:00 pm By:
Using #math to fight #cancer : http://eurekalert.org/e/437h
Nearly 900000 Fewer Cancer Deaths Since 1990: Report - MSN Health - Breast Cancer
health.msn.com — “Researchers credit trend to better detection treatment and drop in smoking” View full resource at health.msn.com
Most Recently Shared on June 17, 2011 at 1:45 pm By:
Nearly 900,000 Fewer Cancer Deaths Since 1990: Report: http://on-msn.com/jzwTZA
BP Rise Predicts Better Sunitinib Response - Renal and Urology News
renalandurologynews.com — “Patients who experience high blood pressure (BP) while being treated with sunitinib for advanced renal cell carcinoma (RCC) respond better to treatment, have improved overall survival, and have longer progression-free survival (PFS), according to a report in the Journal of the National Cancer Institute (2011;103;763-773).” View full resource at renalandurologynews.com
Most Recently Shared on June 9, 2011 at 1:18 pm By:
Renal Urology News Health News, Nephrology, Urology, and Medical Publisher
BP Rise Predicts Better Sunitinib Response: Patients who experience high blood pressure (BP) while being treated... http://bit.ly/mkfGxE
Studies Report Results Defining New Standards Of Clinical Cancer Care
medicalnewstoday.com — “Studies describing progress in establishing new treatment standards against advanced cancers, specifically melanoma and neuroblastoma, were released today at a press briefing at the 47th Annual Me” View full resource at medicalnewstoday.com
Most Recently Shared on June 6, 2011 at 9:05 am By:
MNT Pediatrics News Pediatrics and Health News
Studies Report Results Defining New Standards Of Clinical Cancer Care http://mnt.to/3WN8 #pediatrics
Optimizing Treatment for Metastatic Clear Cell Renal Cell Carcinoma: US Oncologist Survey - Market Research Reports - Research and Markets
researchandmarkets.com — “Two patient specific case scenarios that unfold throughout the report, presented to 119 high-prescribing oncologists on Metastatic Clear Cell Renal Cell Cancer for their open responses on clinical decisions Patient progression reveals decisions in treatment throughout patient stages, factors...” View full resource at researchandmarkets.com
Most Recently Shared on April 14, 2011 at 2:48 pm By:
Kidney Cancer Health Executive
Report: Optimizing Treatment for Kidney Cancer http://bit.ly/gPBUkw
Distribution of cancers in the HIV/AIDS population is shifting, April 11, 2011 News Release - National Institutes of Health (NIH)
nih.gov — “As treatments for HIV/AIDS improve and patients are living longer, the distribution of cancers in this population has undergone a dramatic shift in the United States. While cases of the types of cancer that have been associated with AIDS progression have decreased, cases of other types of cancer are on the rise. These results, reported by scientists from the National Cancer Institute (NCI), part of the National Institutes of Health, and the Centers for Disease Control and Prevention, were publis” View full resource at nih.gov
Most Recently Shared on April 11, 2011 at 8:18 pm By:
David Flores - Einstein College of Medicine Medical School
RT @NIHforHealth: News: Distribution of cancers in the HIV/AIDS population is shifting http://1.usa.gov/e8VEdB
Cancer Trends Progress Report - Weight
progressreport.cancer.gov — “A profile of the nation's current cancer risks, rates, and mortality, as well as progress toward their reduction” View full resource at progressreport.cancer.gov
Most Recently Shared on November 22, 2010 at 4:12 pm By:
RT @hutchinsonctr: RT @NCIprevention: 20% colon, postmenopausal breast, other cancer related overweight, lack exercise http://go.usa.gov/Ct0
Orexo's Abstral sales increases 345% to 14.1m
news-medical.net — “Orexo AB announces that its sales partner in the EU and USA for Abstral, ProStrakan Group plc yesterday issued its interim report, which gave further information on progress with Abstral, Orexo's leading sublingual fentanyl product for treatment of breakthrough cancer pain.” View full resource at news-medical.net
Most Recently Shared on November 16, 2010 at 11:28 am By:
Orexo's Abstral sales increases 345% to £14.1m: Orexo AB announces that its sales partner in the EU and USA for ... http://bit.ly/c6NKDT
Erlotinib improves progression-free survival as first-line therapy in advanced lung cancer, study finds
sciencedaily.com — “For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospective Phase III study to report findings in this setting.” View full resource at sciencedaily.com
Most Recently Shared on October 18, 2010 at 3:05 am By:
Erlotinib improves progression-free survival as first-line therapy in advanced lung cancer, study finds: For patie... http://bit.ly/ba1gV6
Erlotinib improves progression-free survival as first-line therapy in advanced lung cancer, study finds
sciencedaily.com — “For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospective Phase III study to report findings in this setting.” View full resource at sciencedaily.com
Most Recently Shared on October 18, 2010 at 2:13 am By:
Erlotinib improves progression-free survival as first-line therapy in advanced lung cancer, study finds: For patie... http://bit.ly/dbah6d
ESMO: No Help from PARP Inhibitor in Ovarian Cancer (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “MILAN (MedPage Today) -- Patients with progressive BRCA-related ovarian cancer got no significant benefit from treatment with an agent that targets the PARP pathway, researchers reported here.” View full resource at qualitypointtech.net
Most Recently Shared on October 13, 2010 at 10:49 pm By:
ESMO: No Help from PARP Inhibitor in Ovarian Cancer (CME/CE): MILAN (MedPage Today) -- Patients with progressive B... http://bit.ly/cjqwfY
New Phase II Study Shows First-Line Promise Of Lung Cancer Drug PF-299
medicalnewstoday.com — “A new-generation lung cancer drug has shown an impressive ability to prevent disease progression when administered as a first-line treatment in patients with advanced disease, investigators report” View full resource at medicalnewstoday.com
Most Recently Shared on October 13, 2010 at 2:05 pm By:
New Phase II Study Shows First-Line Promise Of Lung Cancer Drug PF-299 http://mnt.to/3L7J #lungcancer
Advertisement
